Pharmacological basis for functional selectivity of partial muscarinic receptor agonists

Author： Heldman E.   Barg J.   Fisher A.   Levy R.   Pittel Z.   Zimlichman R.   Kushnir M.   Vogel Z.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.297, Iss.3, 1996-02, pp. : 283-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Muscarinic receptor agonists and antagonists

By Zlotos D.P.   Bender W.   Holzgrabe U.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. : 1029-1053

Informa Healthcare

Access to resources Recommend Favorite

Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 488-501

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological evidence of muscarinic receptor heterodimerization

By Chiacchio S.   Scarselli M.   Armogida M.   Maggio R.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 315-326

Elsevier

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

Partial agonists and G protein-coupled receptor desensitization

By Clark R.B.   Knoll B.J.   Barber R.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 7, 1999-07 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite